Dexamethasone suppresses cochlear Hes1 expression after noise exposure

Area of Science:

• Ototolaryngology
• Neuroscience
• Pharmacology

Background:

• Noise-induced hearing loss (NIHL) is a significant health concern.
• The hairy and enhancer of split 1 (Hes1) gene plays a role in cochlear development and function.
• Dexamethasone is a corticosteroid with anti-inflammatory properties.

Purpose of the Study:

• To investigate the role of Hes1 in the protective effects of dexamethasone against NIHL.
• To explore the mechanism by which dexamethasone prevents NIHL.

Main Methods:

• Guinea pigs were treated with dexamethasone, a glucocorticoid receptor (GR) antagonist (RU38,486), or both, followed by noise exposure.
• Auditory brainstem response (ABR) thresholds and outer hair cell survival were assessed.
• Hes1 expression levels in the cochlea were quantified using real-time RT-PCR and Western blot.

Main Results:

• Noise exposure caused hearing threshold elevations, outer hair cell loss, and increased Hes1 expression.
• Dexamethasone pretreatment significantly reduced NIHL and decreased Hes1 expression.
• The protective effect of dexamethasone was blocked by the GR antagonist RU38,486, indicating GR-dependent action.

Conclusions:

• Dexamethasone confers protection against NIHL.
• This protection is associated with the suppression of cochlear Hes1 expression.
• The mechanism involves the glucocorticoid receptor (GR) pathway.